TipRanks

Notifications

Tag: GBT

Total 55 Posts

Analysts Are Neutral on Top Healthcare Stocks: Global Blood Therapeutics (GBT), Cerevel Therapeutics Holdings (CERE)

Analysts fell to the sidelines weighing in on Global Blood Therapeutics (GBTResearch Report) and Cerevel Therapeutics Holdings (CEREResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Global Blood Therapeutics (GBT)

In a report released today, Andreas Argyrides from Wedbush downgraded Global Blood Therapeutics to Hold, with a price target of $68.50. The company’s shares closed last Monday at $66.67, close to its 52-week high of $73.02.

According to TipRanks.com, Argyrides is a 2-star analyst with an average return of 2.3% and a 45.8% success rate. Argyrides covers the Healthcare sector, focusing on stocks such as Rani Therapeutics Holdings, BioMarin Pharmaceutical, and Clearside Biomedical.

Global Blood Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $60.50, representing a -9.3% downside. In a report released today, Jefferies also downgraded the stock to Hold with a $68.50 price target.

See the top stocks recommended by analysts >>

Cerevel Therapeutics Holdings (CERE)

In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Cerevel Therapeutics Holdings, with a price target of $27.00. The company’s shares closed last Monday at $34.54.

According to TipRanks.com, Suvannavejh is a 2-star analyst with an average return of 1.0% and a 51.5% success rate. Suvannavejh covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Intra-Cellular Therapies, and Bioxcel Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cerevel Therapeutics Holdings with a $38.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on GBT: